UNSPSC 51401503: Chlordiazepoxide

This classification denotes a benzodiazepine with the molecular formula C16H14ClN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6RZ6XEZ3CR, chemically known as 7-chloro-n-methyl-5-phenyl-3h-1,4-benzodiazepin-2-amine 4-oxide but generally known as chlordiazepoxide, which bears US NIH Compound Identifier 2712. European Medicines Agency schedules Chlordiazepoxide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06179MIG.

UNSPSC 51401503 Chlordiazepoxide, a Commodity code, nominally encompasses pharmaceutical procurement but shows minimal alignment with recent state and local activity tagged under it. The single recent solicitation on record, Seminole County's IFB 60459723LAS, targets naloxone and safe drug deactivation systems for community health initiatives—a harm-reduction and emergency-response product line distinctly outside the scope of chlordiazepoxide, a benzodiazepine anxiolytic. State and local procurement offices appear to apply this code inconsistently or opportunistically when pharmaceutical goods fall outside more precisely matched taxonomy entries. Issuing activity centers on county health departments and special-purpose health authorities pursuing emergency medical supplies and public-health interventions rather than controlled-substance pharmaceuticals.

Seminole County, Florida is the only recent issuer represented in the data, with an IFB posted June 30, 2026, and a response deadline of July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually on a competitive bid basis with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract term runs two years with an option for one-year renewal; bidders must include all shipping and delivery costs, maintain specified insurance coverages, obtain drug-free workplace certification, and comply with E-Verify requirements. The solicitation does not cite explicit set-aside designations. Geographic activity is limited to Florida in available records. The taxonomy mismatch and sparse recent-opportunity volume suggest this code does not reliably capture state and local chlordiazepoxide procurement or related benzodiazepine buys; firms pursuing controlled-substance pharmaceutical contracts should verify actual issuing-body UNSPSC tagging before relying on this classification.